Somaxon Pharmaceuticals, Inc.

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . GSK Teams With Lyell On Soli

Pernix Therapeutics Holdings Inc. is in the midst of a transformation, led by a new management team that has put together a portfolio of specialty drugs for the treatment of central nervous system d

Our review of biopharma dealmaking – for the third quarter of 2013. Our data come from Elsevier’s Strategic Transactions . Financings Biopharma companies closed the third quarter of 2013 with an agg

Somaxon CEO moves to Apricus Apricus Biosciences Inc. appoints Richard Pascoe as CEO and to the board of directors. Pascoe moves from Somaxon Pharmaceuticals Inc. , where as CEO he led the firm